-Secretase revealed: starting gate for race to novel therapies for Alzheimer's disease

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.21, Iss.5, 2000-05, pp. : 161-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012

By Pettersson Martin Stepan Antonia F Kauffman Gregory W Johnson Douglas S

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1349-1366

Informa Healthcare

Access to resources Recommend Favorite

Neuroprotective Therapies for Alzheimer's Disease

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 705-717

Bentham Science Publishers

Access to resources Recommend Favorite

Human β-secretase and Alzheimer’s disease

By Citron Martin

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 3, 2001-06 ,pp. : 341-348

Informa Healthcare

Access to resources Recommend Favorite

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 1, 2017-02 ,pp. : 3-25

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches to Palliative Therapies for Alzheimer's Disease

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 6, 2006-03 ,pp. : 553-568

Bentham Science Publishers

Access to resources Recommend Favorite